Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...
Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...
Reports Q4 revenue $200.7M, consensus $202.8M. “Our performance in 2024 reflects the strength of our core businesses, as Genomics continued to ...
Would you like to be notified of the latest news and updates on the stock market?
Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...
Tempus AI Inc (TEM) reports impressive revenue growth, strategic acquisitions, and extended partnerships, setting the stage for a promising 2025.
Despite optimistic news from the CEO yesterday afternoon, the company's shares fell overnight and a major investment house ...
Tempus posted a fourth-quarter adjusted net loss of $0.18 per share, $0.02 more per share than estimates by analysts surveyed by Visible Alpha. Revenue jumped 36% year-over-year to $200.7 million, but ...
We recently published a list of 10 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at ...